BHONSLE SUNIL 4
4 · TITAN PHARMACEUTICALS INC · Filed Sep 25, 2018
Insider Transaction Report
Form 4
BHONSLE SUNIL
DirectorPresident
Transactions
- Purchase
Common Stock
2018-09-21$0.25/sh+300,000$75,000→ 435,578 total - Award
Warrants
2018-09-21+300,000→ 300,000 totalExercise: $0.25From: 2023-09-25Exp: 2023-09-25→ common stock (300,000 underlying)
Holdings
- 54,684(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The reporting person serves as trustee of the family trust.